Sec-Butyl Cinnamate

Sec-Butyl Cinnamate

SCHEMBL7530104

CCC(C)OC(=O)C=Cc1ccccc1

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.59
MEN1 O00255 1/20 0.59
TDP1 Q9NUW8 2/20 0.53
GLA P06280 1/20 0.53
LMNA P02545 3/20 0.51
AKR1B10 O60218 2/20 0.51
AKR1B1 P15121 2/20 0.51
CA12 O43570 1/20 0.51
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
CA7 P43166 1/20 0.51
CA9 Q16790 1/20 0.51
CA14 Q9ULX7 1/20 0.51
ALDH1A1 P00352 2/20 0.51
MAOA P21397 1/20 0.49
MAOB P27338 1/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
NPC1 O15118 2/20 0.49
MMP1 P03956 1/20 0.48
MAPT P10636 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sec-Butyl Cinnamate SCHEMBL13688230 1.00 KMT2A (0.59) KMT2AMEN1TDP1GLALMNA
Sec-Butyl Cinnamate SCHEMBL13347964 1.00 KMT2A (0.59) KMT2AMEN1TDP1GLALMNA
SCHEMBL19244268 0.91 MAPT (0.53) KMT2AMEN1TDP1GLAAKR1B10
SCHEMBL19244269 0.91 MAPT (0.53) KMT2AMEN1TDP1GLAAKR1B10
SCHEMBL15163756 0.89 MEN1 (0.49) KMT2AMEN1TDP1GLALMNA
SCHEMBL14356149 0.89 MEN1 (0.49) KMT2AMEN1TDP1GLALMNA
SCHEMBL14160230 0.89 KMT2A (0.49) KMT2AMEN1TDP1GLAAKR1B10
SCHEMBL5079340 0.89 KMT2A (0.60) KMT2AMEN1TDP1GLALMNA
SCHEMBL30249969 0.89 KMT2A (0.60) KMT2AMEN1TDP1GLALMNA
SCHEMBL5079339 0.89 KMT2A (0.60) KMT2AMEN1TDP1GLALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002015691-A1 USE FOR CONIFER SAPLING PROTECTION AGAINST INSECT ATTACK ROBIGUS AB (SE) 2002-02-28 WO claimed
EP-3689849-B1 PERFUME PRECURSOR TAKASAGO PERFUMERY CO LTD (JP) 2025-01-15 EP disclosed
EP-3661900-B1 IRON-CATALYZED TRANSFER HYDROGENATION OF ESTERS TO ALCOHOLS EASTMAN CHEM CO (US) 2023-11-01 EP disclosed
CN-111032603-B Iron-catalyzed transesterification hydrogenation of esters to alcohols 伊士曼化工公司 2023-07-25 CN disclosed
WO-2020142273-A1 COMPOSITIONS AND METHODS FOR REMOVING COATINGS FROM SURFACES FOURTH PRINCIPLE, LLC (US) 2020-07-09 WO disclosed
EP-3661900-A1 IRON-CATALYZED TRANSFER HYDROGENATION OF ESTERS TO ALCOHOLS Eastman Chemical Company (US) 2020-06-10 EP disclosed
CN-111032603-A Iron-catalyzed transfer hydrogenation of esters to alcohols 伊士曼化工公司 2020-04-17 CN disclosed
US-10266466-B2 Iron-catalyzed transfer hydrogenation of esters to alcohols EASTMAN CHEMICAL COMPANY (US) 2019-04-23 US disclosed
EP-3208301-B1 RESIN COMPOSITION AND OPTICAL COMPENSATION FILM USING SAME TOSOH CORP (JP) 2019-04-03 EP disclosed
WO-2019027967-A1 IRON-CATALYZED TRANSFER HYDROGENATION OF ESTERS TO ALCOHOLS EASTMAN CHEMICAL COMPANY (US) 2019-02-07 WO disclosed
US-20190039977-A1 IRON-CATALYZED TRANSFER HYDROGENATION OF ESTERS TO ALCOHOLS EASTMAN CHEMICAL COMPANY (US) 2019-02-07 US disclosed
US-10126478-B2 Resin composition and optical compensation film using same TOSOH CORPORATION (JP) 2018-11-13 US disclosed
US-20170242174-A1 RESIN COMPOSITION AND OPTICAL COMPENSATION FILM USING SAME TOSOH CORPORATION (JP) 2017-08-24 US disclosed
EP-3208301-A1 RESIN COMPOSITION AND OPTICAL COMPENSATION FILM USING SAME Tosoh Corporation (JP) 2017-08-23 EP disclosed
US-7300688-B2 Alignment layer comprising a first and second sublayer STICHTING DUTCH POLYMER INSTITUTE (NL) 2007-11-27 US disclosed
WO-2002015691-A1 USE FOR CONIFER SAPLING PROTECTION AGAINST INSECT ATTACK ROBIGUS AB (SE) 2002-02-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190039977-A1 IRON-CATALYZED TRANSFER HYDROGENATION OF ESTERS TO ALCOHOLS FTH1, CYP4F12, TFRC KMT2A 1384/4885MEN1 1800/4885TDP1 4739/4885
US-10266466-B2 Iron-catalyzed transfer hydrogenation of esters to alcohols FTH1, CYP4F12, TFRC KMT2A 1384/4885MEN1 1800/4885TDP1 4739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.